Cite
HARVARD Citation
Inagaki, Y. et al. (2020). Comment on: 'Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer'. Lung cancer. pp. 179-180. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Inagaki, Y. et al. (2020). Comment on: 'Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer'. Lung cancer. pp. 179-180. [Online].